Evaluation of a Cerebral-Blood-Volume (CBV) Pharmaco-MRI (PhMRI) Assay Utilizing Low (0.1mg/70kg) and High (0.2mg/70kg) Dose Buprenorphine Infusion and a Novel USPIO Contrast Agent (Ferumoxytol) in Healthy Human Subjects.